Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Strattera (atomoxetine) Treatment Report
What is Strattera?

Strattera® is a brand name for the drug atomoxetine HCL, a selective norepinephrine reuptake inhibitor used in the treatment of attention deficit hyperactivity disorder (ADHD).

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 4 0
Brain fog 3 1
Depression 2 0
Fatigue 2 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 50%
None
1 50%

Dosages

  daily 18 mg daily 25 mg daily 30 mg daily 60 mg daily 80 mg daily 100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Strattera (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%

See all 1 patient who’ve stopped taking Strattera

Duration See details about how long patients take this treatment ▼

Currently Taking Strattera

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
3
1

Stopped Taking Strattera

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
2 100%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.